JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GOLDMAN, J. M.
Right arrow Articles by HADLEY, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GOLDMAN, J. M.
Right arrow Articles by HADLEY, M. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 166, Issue 1, 1-7, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


IN VITRO DEMONSTRATION OF ADRENERGIC RECEPTORS CONTROLLING MELANOPHORE RESPONSES OF THE LIZARD, ANOLIS CAROLINENSIS

JOEL M. GOLDMAN 1 and MAC E. HADLEY 1

1 Department of Biological Sciences and Division of Pharmacology, College of Pharmacy, University of Arizona, Tucson, Arizona

Catecholamines cause both melanin granule aggregation (skin lightening) and dispersion (skin darkening) within melanophores of the lizard, Anolis carolinensis. In vitro experiments were designed to demonstrate and characterize the nature of the adrenergic receptors mediating these responses. Isoproterenol (ISO) darkened skins in Ringer's solution, whereas phenylephrine (PE) lightened them. Norepinephrine (NE) and epinephrine (E) also lightened the skins, but in some experiments they caused darkening. These sympathomimetic agents could be ranked as to their relative effectiveness in lightening skins in Ringer's solution in the following order: PE > NE > E > ISO. These agents could also be ranked as to their ability to lighten skins darkened by melanocyte-stimulating hormone in the following order: NE ge E » PE ge ISO, again a demonstration of an alpha receptor-mediated response. Ergotamine prevented sympathomimetic induced lightening of skins darkened by melanocyte-stimulating hormone.

Dibenamine and phentolamine prevented skin lightening in response to sympathomimetic stimulation. This blockade resulted in NE and E causing an intense darkening of skins due to a classical "epinephrine reversal" resulting from beta stimulation by these agonists. After alpha blockade the sympathomimetic agents darkened skins in the following order of relative effectiveness: ISO > E > NE > PE, the ranking for characterizing a beta adrenergic receptor-mediated response. These agonists have a similar order with respect to their darkening of skins maintained solely in Ringer's solution. Dichloroisoproterenol prevented skin darkening in response to sympathomimetic stimulation. These results reveal that alpha receptors mediate melanin granule aggregation and that beta receptors control melanin granule dispersion within Anolis melanophores in vitro in response to sympathomimetic stimulation.

Submitted on May 16, 1968
Accepted on November 7, 1968




This article has been cited by other articles:


Home page
Integr. Comp. Biol.Home page
N. Greenberg
Ethological Aspects of Stress in a Model Lizard, Anolis carolinensis
Integr. Comp. Biol., July 1, 2002; 42(3): 526 - 540.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. Bower, M. E. Hadley, and V. J. Hruby
Biogenic Amines and Control of Melanophore Stimulating Hormone Release
Science, April 5, 1974; 184(4132): 70 - 72.
[Abstract] [PDF]


Home page
ScienceHome page
D. L. Vesely and M. E. Hadley
Calcium Requirement for Melanophore-Stimulating Hormone Action on Melanophores
Science, September 3, 1971; 173(4000): 923 - 925.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.